Cargando…
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
Failure to translate successful neuroprotective preclinical data to a clinical setting in Alzheimer's disease (AD) indicates that amyloidopathy and tauopathy alone provide an incomplete view of disease. We have tested here the relevance of additional homeostatic deviations that result from loss...
Autores principales: | Rojo, Ana I., Pajares, Marta, Rada, Patricia, Nuñez, Angel, Nevado-Holgado, Alejo J., Killik, Richard, Van Leuven, Fred, Ribe, Elena, Lovestone, Simon, Yamamoto, Masayuki, Cuadrado, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508523/ https://www.ncbi.nlm.nih.gov/pubmed/28704727 http://dx.doi.org/10.1016/j.redox.2017.07.006 |
Ejemplares similares
-
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy
por: Rojo, Ana I., et al.
Publicado: (2018) -
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
por: Nevado-Holgado, Alejo J, et al.
Publicado: (2016) -
Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
por: Pajares, Marta, et al.
Publicado: (2016) -
Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer’s Disease Therapeutic Development
por: Nevado-Holgado, Alejo J., et al.
Publicado: (2019) -
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
por: Winchester, Laura M., et al.
Publicado: (2018)